FDA aims to give full approval to Pfizer vaccine by Labor Day

The Food and Drug Administration (FDA) is aiming to give full approval to the Pfizer coronavirus vaccine by Labor Day, multiple people familiar with the discussions told The New York Times.

The FDA has faced pressure to fully approve the vaccine after Pfizer applied for full approval on May 7. Pfizer's vaccine and another from Moderna have been under emergency authorization since December; Moderna applied for full approval June 1.